Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statement of Cash Flows (Unaudited)

v3.26.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ 5,093 $ (7,017)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Gain on sale of assets, net of cash (15,311)
Depreciation and amortization 134 1,852
Stock-based compensation ($309 from continuing and $93 from discontinued operations for 2026 and all from discontinued operations for 2025-see Note 8) 402 1,216
Loss on remeasurement of derivative liability 238
Gain on extinguishment of debt (191)
Release of customer allowance liability (5,490)
Impairment of contract fulfillment assets 1,084
Investment income from DNA X LLC under the equity method (48)
Other 36
Changes in operating assets and liabilities:    
Accounts receivable 250 1,330
Non-trade receivable 94 152
Deferred tax liability 600
Deferred tax asset 1,364
Inventory 5,490 986
Prepaid expenses and other current assets 1,512 (589)
Contract fulfillment assets 129 (4,383)
Other assets (74) (18)
Accounts payable (2,672) (2,265)
Accrued liabilities (2,009) (1,433)
Income tax payable (468) 51
Net cash used in operating activities (5,467) (14,488)
Cash flows from investing activities:    
Net cash received from asset sale 3,358
Additions to identifiable intangibles - software assets (94)
Net cash provided by investing activities 3,264
Cash flows from financing activities:    
Proceeds from issuance of common stock, net of issuance costs 8,952
Proceeds from promissory note, net of issuance costs 1,800 2,790
Repayments of short-term borrowings (591)
Net cash provided by financing activities 1,800 11,151
Net decrease in cash and cash equivalents (403) (3,337)
Cash and cash equivalents at beginning of period 1,303 5,343
Cash and cash equivalents at end of period 900 2,006
Supplemental disclosure of cash flow information:    
Cash paid for interest 257 241
Cash paid for income taxes 28
Supplemental disclosure of non-cash activities:    
Repayment of notes payable from proceeds of asset sale 5,476
Receivable for cash held back from asset sale 1,248
Reclass of investment to intangibles, related party receivables, and accrued liabilities 1,290
Accrued bonus settled in equity $ 1,215